Considerations for and Mechanisms of Adjunct Therapy in COPD
Open Access
- 16 March 2021
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (6) , 1225
Abstract
Inhaled bronchodilators and corticosteroids, when indicated, form the backbone of COPD therapy. However, over the last decade there has been an emergence of adjunct therapies in oral or inhaled form that are now part of the therapeutic approach to COPD. While these therapies have shown to be beneficial when used in the appropriate instances, there are particular considerations that need to be minded when using these therapies. This review article discussed the mechanism of roflumilast, macrolide antibiotics, other chronic antibiotic regimens, vitamin D supplementation, oral corticosteroids, n-acetylcysteine, and nebulized hypertonic saline, the clinical data behind each of these therapies, adverse events associated with therapy, and the expert recommendations for their utilization. Our goal is to provide a brief but informative and clinically useful review of commonly encountered therapies used in advanced COPD.Keywords
This publication has 63 references indexed in Scilit:
- Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trialRespiratory Research, 2012
- Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1The Journal of Immunology, 2012
- Mechanisms and applications of hypertonic salineJournal of the Royal Society of Medicine, 2011
- Azithromycin inhibits nontypeable Haemophilus influenzae-induced MUC5AC expression and secretion via inhibition of activator protein-1 in human airway epithelial cellsEuropean Journal of Pharmacology, 2010
- Infection as a comorbidity of COPDEuropean Respiratory Journal, 2010
- Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trialRespiratory Research, 2010
- The Vitamin D–Antimicrobial Peptide Pathway and its Role in Protection Against InfectionFuture Microbiology, 2009
- The paradoxical effects of vitamin D on type 1 mediated immunityMolecular Aspects of Medicine, 2008
- Erythromycin increases bactericidal activity of surface liquid in human airway epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- PDE4 inhibitors as new anti-inflammatory drugs: Effects on cell trafficking and cell adhesion molecules expressionPharmacology & Therapeutics, 2005